Chip-based analysis of circulating nucleic acids in cancer patients published in Nature Chemistry

Mon, 01 Jun 2015

Noninvasive monitoring of the molecular-level properties of patient tumors is an important capability for the delivery of personalized medicine and precision oncology.  Our group has developed an electrochemical clamp assay, which provides an alternative to PCR or sequencing that is cost-effective and simple to automate. In addition, this new technology has a significant advantage over existing methods as there is no need for a blood purification step before the analysis is conducted.  The paper describing this approach was published today in Nature Chemistry.